WASHINGTON, D.C., October 12, 2021 – The U.S. Food and Drug Administration today issued marketing denial orders for 10 flavored e-cigarettes sold by R.J. Reynolds (RJR) Vapor Company under the Vuse Solo brand. The FDA also issued orders allowing RJR to market its Vuse Solo e-cigarette and accompanying tobacco-flavored e-liquid pods.
Following is a statement from the American Heart Association:
“The FDA is right to continue to deny authorization for tobacco companies to sell flavored e-cigarettes, which have fueled the nicotine epidemic among youth nationwide and put millions of kids at risk for a lifetime of tobacco use and addiction.
“The FDA should follow today’s announcement by also denying RJR’s application for Vuse Solo menthol flavor cartridges. For decades, tobacco companies have aggressively marketed menthol-flavored tobacco products to Black communities, other groups of color and youth, fueling a scourge of nicotine addiction.
“The FDA’s authorization of Vuse Solo in tobacco flavor will require continued vigilance on purchasing patterns and youth uptake and utilization. We must ensure youth don’t gravitate to tobacco-flavored e-cigarettes, enabling the tobacco industry to sustain the nicotine epidemic.”
About the American Heart Association
The American Heart Association is a leading force for a world of longer, healthier lives. With nearly a century of lifesaving work, the Dallas-based association is dedicated to ensuring equitable health for all. We are a trustworthy source empowering people to improve their heart health, brain health and well-being. We collaborate with numerous organizations and millions of volunteers to fund innovative research, advocate for stronger public health policies and share lifesaving resources and information. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.
For media inquiries please contact: